APO RESEARCH · REPORT
Biological Indicators
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Product & engineering
Understand the product.
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Selected research
Industry Research
Biological Indicators Industry Research Report 2026
Market perspective
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.
Report Scope
Read the full market overview
This report quantifies the global Biological Indicators market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biological Indicators.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biological Indicators Market by Company
3M
Getinge Group
Cantel Medical
Mesa Laboratories
Steris
Fuze Medical
Matachana
Hu-Friedy
Advanced Sterilization
Bag Health Care
Terragene
Andersen
GKE
Biological Indicators Segment by Type
Self-Contained Biological Indicator
Biological Indicator Strip
Biological Indicators Segment by Application
Hospital
Pharma Companies
Others
Biological Indicators Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Indicators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biological Indicators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Indicators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biological Indicators companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Self-Contained Biological Indicator
- Biological Indicator Strip
Applications
- Hospital
- Pharma Companies
- Others
Companies covered
- 3M
- Getinge Group
- Cantel Medical
- Mesa Laboratories
- Steris
- Fuze Medical
- Matachana
- Hu-Friedy
- Advanced Sterilization
- Bag Health Care
- Terragene
- Andersen
- GKE
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biological Indicators by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Self-Contained Biological Indicator
- 2.2.3 Biological Indicator Strip
- 2.3 Biological Indicators by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Pharma Companies
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Biological Indicators Breakdown Data by Type
- 3.1 Global Biological Indicators Historic Market Size by Type (2021-2026)
- 3.2 Global Biological Indicators Forecasted Market Size by Type (2027-2032)
4 Biological Indicators Breakdown Data by Application
- 4.1 Global Biological Indicators Historic Market Size by Application (2021-2026)
- 4.2 Global Biological Indicators Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biological Indicators Market Perspective (2021-2032)
- 5.2 Global Biological Indicators Growth Trends by Region
- 5.2.1 Global Biological Indicators Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biological Indicators Historic Market Size by Region (2021-2026)
- 5.2.3 Biological Indicators Forecasted Market Size by Region (2027-2032)
- 5.3 Biological Indicators Market Dynamics
- 5.3.1 Biological Indicators Industry Trends
- 5.3.2 Biological Indicators Market Drivers
- 5.3.3 Biological Indicators Market Challenges
- 5.3.4 Biological Indicators Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biological Indicators Players by Revenue
- 6.1.1 Global Top Biological Indicators Players by Revenue (2021-2026)
- 6.1.2 Global Biological Indicators Revenue Market Share by Players (2021-2026)
- 6.2 Global Biological Indicators Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biological Indicators Head Office and Area Served
- 6.4 Global Biological Indicators Players, Product Type & Application
- 6.5 Global Biological Indicators Manufacturers Established Date
- 6.6 Global Biological Indicators Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biological Indicators Market Size (2021-2032)
- 7.2 North America Biological Indicators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biological Indicators Market Size by Country (2021-2026)
- 7.4 North America Biological Indicators Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biological Indicators Market Size (2021-2032)
- 8.2 Europe Biological Indicators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biological Indicators Market Size by Country (2021-2026)
- 8.4 Europe Biological Indicators Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biological Indicators Market Size (2021-2032)
- 9.2 Asia-Pacific Biological Indicators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biological Indicators Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biological Indicators Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biological Indicators Market Size (2021-2032)
- 10.2 South America Biological Indicators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biological Indicators Market Size by Country (2021-2026)
- 10.4 South America Biological Indicators Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biological Indicators Market Size (2021-2032)
- 11.2 Middle East & Africa Biological Indicators Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biological Indicators Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biological Indicators Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 3M
- 12.1.1 3M Company Information
- 12.1.2 3M Business Overview
- 12.1.3 3M Revenue in Biological Indicators Business (2021-2026)
- 12.1.4 3M Biological Indicators Product Portfolio
- 12.1.5 3M Recent Developments
- 12.2 Getinge Group
- 12.2.1 Getinge Group Company Information
- 12.2.2 Getinge Group Business Overview
- 12.2.3 Getinge Group Revenue in Biological Indicators Business (2021-2026)
- 12.2.4 Getinge Group Biological Indicators Product Portfolio
- 12.2.5 Getinge Group Recent Developments
- 12.3 Cantel Medical
- 12.3.1 Cantel Medical Company Information
- 12.3.2 Cantel Medical Business Overview
- 12.3.3 Cantel Medical Revenue in Biological Indicators Business (2021-2026)
- 12.3.4 Cantel Medical Biological Indicators Product Portfolio
- 12.3.5 Cantel Medical Recent Developments
- 12.4 Mesa Laboratories
- 12.4.1 Mesa Laboratories Company Information
- 12.4.2 Mesa Laboratories Business Overview
- 12.4.3 Mesa Laboratories Revenue in Biological Indicators Business (2021-2026)
- 12.4.4 Mesa Laboratories Biological Indicators Product Portfolio
- 12.4.5 Mesa Laboratories Recent Developments
- 12.5 Steris
- 12.5.1 Steris Company Information
- 12.5.2 Steris Business Overview
- 12.5.3 Steris Revenue in Biological Indicators Business (2021-2026)
- 12.5.4 Steris Biological Indicators Product Portfolio
- 12.5.5 Steris Recent Developments
- 12.6 Fuze Medical
- 12.6.1 Fuze Medical Company Information
- 12.6.2 Fuze Medical Business Overview
- 12.6.3 Fuze Medical Revenue in Biological Indicators Business (2021-2026)
- 12.6.4 Fuze Medical Biological Indicators Product Portfolio
- 12.6.5 Fuze Medical Recent Developments
- 12.7 Matachana
- 12.7.1 Matachana Company Information
- 12.7.2 Matachana Business Overview
- 12.7.3 Matachana Revenue in Biological Indicators Business (2021-2026)
- 12.7.4 Matachana Biological Indicators Product Portfolio
- 12.7.5 Matachana Recent Developments
- 12.8 Hu-Friedy
- 12.8.1 Hu-Friedy Company Information
- 12.8.2 Hu-Friedy Business Overview
- 12.8.3 Hu-Friedy Revenue in Biological Indicators Business (2021-2026)
- 12.8.4 Hu-Friedy Biological Indicators Product Portfolio
- 12.8.5 Hu-Friedy Recent Developments
- 12.9 Advanced Sterilization
- 12.9.1 Advanced Sterilization Company Information
- 12.9.2 Advanced Sterilization Business Overview
- 12.9.3 Advanced Sterilization Revenue in Biological Indicators Business (2021-2026)
- 12.9.4 Advanced Sterilization Biological Indicators Product Portfolio
- 12.9.5 Advanced Sterilization Recent Developments
- 12.10 Bag Health Care
- 12.10.1 Bag Health Care Company Information
- 12.10.2 Bag Health Care Business Overview
- 12.10.3 Bag Health Care Revenue in Biological Indicators Business (2021-2026)
- 12.10.4 Bag Health Care Biological Indicators Product Portfolio
- 12.10.5 Bag Health Care Recent Developments
- 12.11 Terragene
- 12.11.1 Terragene Company Information
- 12.11.2 Terragene Business Overview
- 12.11.3 Terragene Revenue in Biological Indicators Business (2021-2026)
- 12.11.4 Terragene Biological Indicators Product Portfolio
- 12.11.5 Terragene Recent Developments
- 12.12 Andersen
- 12.12.1 Andersen Company Information
- 12.12.2 Andersen Business Overview
- 12.12.3 Andersen Revenue in Biological Indicators Business (2021-2026)
- 12.12.4 Andersen Biological Indicators Product Portfolio
- 12.12.5 Andersen Recent Developments
- 12.13 GKE
- 12.13.1 GKE Company Information
- 12.13.2 GKE Business Overview
- 12.13.3 GKE Revenue in Biological Indicators Business (2021-2026)
- 12.13.4 GKE Biological Indicators Product Portfolio
- 12.13.5 GKE Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst